Digestery
Longevity supplements › Resveratrol and Aging › Studies

Systematic review

Review of 28 mostly cell and animal studies: resveratrol helped bone cells

Shuid and colleagues · International journal of molecular sciences · 2025

Original title: A Systematic Review on the Molecular Mechanisms of Resveratrol in Protecting Against Osteoporosis.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

Points to benefit

Of 513 articles found, 28 were included. Authors say resveratrol helped bone-building cells and blocked bone breakdown in lab and animal work. Low absorption is a problem; human studies are needed.

The study at a glance

Type of study
Systematic review
Who or what was studied
28 studies · Mostly cells and animals; one study in postmenopausal women
What was tested
Resveratrol and bone-cell pathways: 14 cell studies, 8 mixed, 6 animal, 1 cross-sectional
What it measured
Lab tests or markers
Who has a stake
No stake declared
No conflicts declared; no sponsor funding.
Journal
International journal of molecular sciences, 2025
Source
PubMed record 40243497. This page is based on the abstract only.

How much this study counts

  • •Sums up 28 studies found with a set search method, without pooling the numbers.
  • –Measured lab tests or markers, which stand in for aging and age-related disease. A better marker does not always mean better health.
  • ✓No competing interests declared.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

This paper is not on the ladder. It is a systematic review, and reviews and opinion pieces discuss studies that are already counted on the steps below.

↑ Stronger evidence

  1. Trials in people: aging and age-related decline

    3

    1 benefit, 1 mixed, 1 no difference

  2. Trials in people: other measures

    3

    1 benefit, 1 mixed, 1 harm

  3. Trials in people: lab tests or safety

    7

    4 benefit, 2 mixed, 1 no difference

  4. Population studies

    1

    1 benefit

  5. Blood levels and genes

    1

    1 no difference

  6. Animals

    1

    1 benefit

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does resveratrol slow aging?”

Not shown in people.

Confidence: very low. Based on 22 on-topic papers.

Read the full answer
  • Summed up in “What reviews found”: Reviewed 28 bone studies: 14 cell, 8 cell-plus-animal, 6 animal and 1 survey of postmenopausal women. Resveratrol helped bone-building pathways in lab work; poor absorption is a problem and human studies are needed.

Other reviews on this question

See all 22 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The reviewer corrected 1 field after reading the abstract. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.